Can Ascletis’ denifanstat reshape acne treatment by targeting fatty acid synthesis?

Ascletis’ acne drug denifanstat advances with NDA acceptance in China. Explore how FASN targeting could disrupt acne care and redefine systemic treatments.

Ascletis’ acne drug denifanstat advances with NDA acceptance in China. Explore how FASN targeting could disrupt acne care and redefine systemic treatments.